Financial reports
10-Q
2024 Q1
Quarterly report
8 Feb 24
10-K/A
2023 FY
Annual report (amended)
26 Jan 24
10-K
2023 FY
Annual report
7 Dec 23
10-Q
2023 Q3
Quarterly report
10 Aug 23
10-Q
2023 Q2
Quarterly report
11 May 23
10-Q
2023 Q1
Quarterly report
9 Feb 23
10-K/A
2022 FY
Annual report (amended)
27 Jan 23
10-K
2022 FY
Annual report
14 Dec 22
10-Q
2022 Q3
Quarterly report
11 Aug 22
10-Q
2022 Q2
Quarterly report
12 May 22
Current reports
8-K/A
Amendments to Articles of Incorporation or Bylaws
23 Apr 24
8-K
Applied DNA Announces 1-For-20 Reverse Stock Split
22 Apr 24
8-K
Entry into a Material Definitive Agreement
19 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
16 Apr 24
8-K
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
8 Feb 24
8-K
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1 Feb 24
8-K
Termination of a Material Definitive Agreement
30 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
8-K
Applied DNA Announces Fourth Quarter Fiscal Year 2023
7 Dec 23
Registration and prospectus
S-1
IPO registration
23 Apr 24
424B3
Prospectus supplement
20 Mar 24
S-1/A
IPO registration (amended)
15 Mar 24
S-1
IPO registration
11 Mar 24
D
$6.87 mm in equity / options / securities to be acquired, 3 investors
12 Feb 24
424B5
Prospectus supplement for primary offering
1 Feb 24
424B5
Prospectus supplement for primary offering
7 Nov 23
S-3
Shelf registration
30 May 23
424B4
Prospectus supplement with pricing info
8 Aug 22
424B4
Prospectus supplement with pricing info
5 Aug 22
Proxies
DEFA14A
Additional proxy soliciting materials
14 Mar 24
DEF 14A
Definitive proxy
14 Mar 24
PRE 14A
Preliminary proxy
4 Mar 24
DEFA14A
Additional proxy soliciting materials
7 Aug 23
DEF 14A
Definitive proxy
7 Aug 23
DEF 14A
Definitive proxy
10 Aug 22
PRE 14A
Preliminary proxy
29 Jul 22
DEFA14A
Additional proxy soliciting materials
29 Jul 22
DEF 14A
Definitive proxy
29 Jul 22
DEF 14A
Definitive proxy
3 Aug 21
Other
EFFECT
Notice of effectiveness
21 Mar 24
EFFECT
Notice of effectiveness
7 Jun 23
CORRESP
Correspondence with SEC
2 Jun 23
UPLOAD
Letter from SEC
2 Jun 23
EFFECT
Notice of effectiveness
5 Aug 22
CORRESP
Correspondence with SEC
2 Aug 22
CORRESP
Correspondence with SEC
2 Aug 22
EFFECT
Notice of effectiveness
28 Jul 22
CORRESP
Correspondence with SEC
25 Jul 22
UPLOAD
Letter from SEC
22 Jul 22
Ownership
SC 13G
Grossman Bruce
12 Feb 24
SC 13G/A
AWM Investment Company, Inc.
10 Jan 24
4
Beth Jantzen
27 Mar 23
4
Clay Shorrock
27 Mar 23
4
Judith Murrah
27 Mar 23
SC 13G
AWM Investment Company, Inc.
14 Feb 23
SC 13G/A
Grossman Bruce
9 Feb 23
4
YACOV A SHAMASH
27 Jan 23
4
Scott L Anchin
27 Jan 23
4
Joseph D. Ceccoli
27 Jan 23